J. Schuettrumpf

Factor V Leiden improves in vivo hemostasis in murine hemophilia models

M. Poncz, V. Arruda, R. Camire, 2005, Journal of thrombosis and haemostasis : JTH.

The inhibitory effects of anticoagulation on in vivo gene transfer by adeno-associated viral or adenoviral vectors.

W. Xiao, V. Arruda, Yi Zhang, 2006, Molecular therapy : the journal of the American Society of Gene Therapy.

Novel hemophilia B mouse models exhibiting a range of mutations in the Factor IX gene.

R. Herzog, K. High, V. Arruda, 2004, Blood.

Safety and efficacy of factor IX gene transfer to skeletal muscle in murine and canine hemophilia B models by adeno-associated viral vector serotype 1.

R. Herzog, T. Nichols, W. Xiao, 2004, Blood.

Factor IX variants improve gene therapy efficacy for hemophilia B.

R. Herzog, V. Arruda, D. Stafford, 2005, Blood.

Inadvertent germline transmission of AAV2 vector: findings in a rabbit model correlate with those in a human clinical trial.

J. Sommer, L. Couto, V. Arruda, 2006, Molecular therapy : the journal of the American Society of Gene Therapy.

603. Correction of Hemophilia B Phenotype by Novel Method of Regional Intravenous Delivery of AAV Vector to Skeletal Muscle of Hemophilia B Dogs

H. Stedman, T. Nichols, K. High, 2005 .

Changing educational paradigms in transfusion medicine

E. Seifried, J. Schuettrumpf, M. M. Mueller, 2011 .

Corrigendum to "Inadvertent Germline Transmission of AAV2 Vector: Findings in a Rabbit Model Correlate with Those in a Human Clinical Trial".

J. Sommer, L. Couto, V. Arruda, 2006, Molecular therapy : the journal of the American Society of Gene Therapy.